Brief: Greenlight Biosciences Holdings reports Q2 results
Aug 15 (Reuters) - Greenlight Biosciences Holdings PBC
GRNA.O :
* GREENLIGHT BIOSCIENCES HOLDINGS PBC- CASH EXPECTED TO FUND
CRITICAL PROGRAMS THROUGH FIRST HALF OF 2023
* GREENLIGHT BIOSCIENCES HOLDINGS PBC- CASH, CASH
EQUIVALENTS, AND
MARKETABLE SECURITIES WERE $44.1 MILLION AS OF JUNE 30, 2022
* GREENLIGHT BIOSCIENCES HOLDINGS PBC- QTRLY EPS $0.42
Source text for Eikon: ID:nGNX1Cn0vg
Further company coverage: GRNA.O
Recent news on Greenlight Biosciences Holdings PBC
See all newsBrief: Greenlight Biosciences To Cut Workforce By About 51%
U.S. RESEARCH ROUNDUP-Microsoft, Chevron, Carisma Therapeutics
U.S. STOCKS ON THE MOVE-Netflix, Hewlett Packard Enterprise, Digital Realty
U.S. STOCKS ON THE MOVE-AI stocks, Broadcom, T2 Biosystems
GreenLight Biosciences gains on deal to be acquired by Fall Line Capital